Intramuscular lorazepam in catatonia in patients with acute renal failure: a report of two cases.

Abstract

Cases of catatonia in patients with renal failure have been rarely reported. In this report, we describe two renal-insufficient patients with catatonia who had a good response to intramuscular lorazepam whereby the catatonic symptoms were relieved. Case 1 involved a patient with end-stage renal disease and severe pneumonia related respiratory failure. He responded well to intramuscular lorazepam (total dose, 4 mg) whereby the catatonia was elieved. Case 2 involved a patient with alcoholic liver cirrhosis and rhabdomyolysis-related acute renal failure. He showed great improvement with intramuscular lorazepam (2 mg) whereby the catatonia was subsequently relieved. This report demonstrates that intramuscular lorazepam is safe, effective and rapid in relieving catatonia associated with renal function impairment. Neither of the patients had a recurrence of catatonia during a period of 6- months follow-up. In conclusion, intramuscular lorazepam may play an important role in the treatment of catatonia associated with renal insufficiency.

• Authors: Chao-En Huang, Tiao-Lai Huang
• Journal: Chang Gung medical journal (Chang Gung Med J) 2010 Jan-Feb Vol. 33 Issue 1 Pg. 106-9 ISSN: 2309-835X [Electronic] China (Republic : 1949- )
• PMID: 20184802 (Publication Type: Case Reports, Journal Article)

Chemical References

• Lorazepam

Topics

• Acute Kidney Injury (complications)
• Catatonia (drug therapy)
• Humans
• Injections, Intramuscular
• Lorazepam (administration & dosage, therapeutic use)
• Male
• Middle Aged